董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Shawn W. Kravetz | 男 | Director | 55 | 未披露 | 未持股 | 2025-10-22 |
| Yvonne E. Schlaeppi | 女 | Director | 65 | 13.25万美元 | 未持股 | 2025-10-22 |
| Alexis P. Michas | 男 | Director | 67 | 未披露 | 未持股 | 2025-10-22 |
| Jorik Ittmann | 男 | President, Chief Executive Officer and Director | 47 | 未披露 | 未持股 | 2025-10-22 |
| Richard S. Warzala | 男 | Director | 71 | 14.38万美元 | 未持股 | 2025-10-22 |
| Mitchell I. Quain | 男 | Director | 73 | 13.87万美元 | 未持股 | 2025-10-22 |
| Alexis P. Michas | 男 | Director | 67 | 12.74万美元 | 未持股 | 2025-10-22 |
| Darius G. Nevin | 男 | Executive Chairman | 67 | 未披露 | 未持股 | 2025-10-22 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Tom Carll | 男 | Senior Vice President, Aerospace | 58 | 26.03万美元 | 未持股 | 2025-10-22 |
| Thomas D. DeByle | 男 | Vice President, Chief Financial Officer and Treasurer | 65 | 未披露 | 未持股 | 2025-10-22 |
| Jorik Ittmann | 男 | President, Chief Executive Officer and Director | 47 | 未披露 | 未持股 | 2025-10-22 |
| Padraig Finn | 男 | Senior Vice President, Product Identification | 43 | 未披露 | 未持股 | 2025-10-22 |
| Michael J. Natalizia | 男 | Vice President, Technology and Strategic Alliances and Chief Technology Officer | 61 | 29.63万美元 | 未持股 | 2025-10-22 |
| Darius G. Nevin | 男 | Executive Chairman | 67 | 未披露 | 未持股 | 2025-10-22 |
董事简历
中英对照 | 中文 | 英文- Shawn W. Kravetz
-
ShawnW.Kravetz是Esplanade Capital LLC的总裁兼首席投资官，该公司是他于1999年创立的一家投资管理公司。该公司管理私人投资合伙企业。从1997年到1999年，他曾担任the Parthenon Group（领先的战略咨询精品店）的负责人，在那里他曾为首席执行官提供企业战略建议。从1995年到1997年，他曾担任CML Group的战略规划和企业发展董事，在那里他曾监管子公司的活动，包括Nordictrack公司、The Nature Company、Smith&Hawken公司。Kravetz先生于1991年以优异成绩在哈佛大学（Harvard University）获得经济学学士学位，并于1995年在哈佛商学院（Harvard Business School）以优异成绩获得工商管理硕士学位。
Shawn W. Kravetz is President and Chief Investment Officer of Esplanade Capital LLC, an investment management company he founded in 1999. The firm manages private investment partnerships. From 1997 until 1999 Mr. Kravetz was a Principal at The Parthenon Group, a leading strategy consulting boutique, where he advised chief executives on corporate strategy. From 1995 until 1997 Mr. Kravetz was Director of Strategic Planning and Corporate Development at the CML Group, where he oversaw activities at subsidiaries including NordicTrack, The Nature Company, and Smith & Hawken. Mr. Kravetz received an A.B. in Economics from Harvard University, magna cum laude, in 1991 and an MBA with High Distinction from Harvard Business School in 1995. - ShawnW.Kravetz是Esplanade Capital LLC的总裁兼首席投资官，该公司是他于1999年创立的一家投资管理公司。该公司管理私人投资合伙企业。从1997年到1999年，他曾担任the Parthenon Group（领先的战略咨询精品店）的负责人，在那里他曾为首席执行官提供企业战略建议。从1995年到1997年，他曾担任CML Group的战略规划和企业发展董事，在那里他曾监管子公司的活动，包括Nordictrack公司、The Nature Company、Smith&Hawken公司。Kravetz先生于1991年以优异成绩在哈佛大学（Harvard University）获得经济学学士学位，并于1995年在哈佛商学院（Harvard Business School）以优异成绩获得工商管理硕士学位。
- Shawn W. Kravetz is President and Chief Investment Officer of Esplanade Capital LLC, an investment management company he founded in 1999. The firm manages private investment partnerships. From 1997 until 1999 Mr. Kravetz was a Principal at The Parthenon Group, a leading strategy consulting boutique, where he advised chief executives on corporate strategy. From 1995 until 1997 Mr. Kravetz was Director of Strategic Planning and Corporate Development at the CML Group, where he oversaw activities at subsidiaries including NordicTrack, The Nature Company, and Smith & Hawken. Mr. Kravetz received an A.B. in Economics from Harvard University, magna cum laude, in 1991 and an MBA with High Distinction from Harvard Business School in 1995.
- Yvonne E. Schlaeppi
-
YvonneE.Schlaeppi，自2018年4月起担任董事。Schlaeppi女士从2011年开始担任Stratevise LLC的管理合伙人，这是一家由她联合创立的国际战略咨询公司。Schlaeppi女士自2014年以来一直担任Stallergenes Greer plc（一家在巴黎泛欧交易所上市的梦百合公司）的董事会成员。Schlaeppi从2014年到2015年担任Allergy Immunotherapy Companies，Ares Allergy Holdings Inc.和Greer Laboratories，Inc.董事。自2015年以来，Schlaeppi女士一直担任波士顿Brigham and Women&8217；s Hospital网络医学部的外部咨询委员会成员。Schlaeppi女士于2017年被美国公司董事协会（National Association of Corporate Directors）认可为董事会领导研究员。在创立Stratevise之前，Schlaeppi女士于2007年至2011年担任全球企业技术公司Passport&ID的总法律顾问，该公司是一家高安全性文档打印解决方案提供商和系统集成商，并担任Organon Biosciences的执行Vice President、总法律顾问和公司IP官，Organon Biosciences是一家全球性制药公司，2006年至2007年，总部设在荷兰的动物保健和生物技术集团。从1999年到2006年，她曾担任Palmer&Dodge公司（位于波士顿的律师事务所）的合伙人，在那里她曾担任该公司的国际实践集团的主席。Schlaeppi女士从1995年到1998年在纽约证券交易所上市的多元化工业公司美国江森自控有限公司担任高级职位，包括担任欧洲总法律顾问。
Yvonne E. Schlaeppi has been a director since April 2018. Since 2011, Ms. Schlaeppi has served as a Managing Partner of Stratevise LLC, an international strategic advisory firm that she co founded. From 2022 through its sale in 2024, Ms. Schlaeppi served on the board of OpGen, Inc., a NASDAQ listed molecular diagnostics company. From 2016 through its going private in 2019, Ms. Schlaeppi served on the board of directors of Stallergenes Greer plc, a pharmaceutical company traded on the Euronext Paris exchange. From 2014 to 2015, Ms. Schlaeppi served on the boards of directors of allergy immunotherapy companies, Ares Allergy Holdings Inc. and Greer Laboratories, Inc. Since 2015, Ms. Schlaeppi has been a member of the External Advisory Council to the Channing Division of Network Medicine of Brigham and Women's Hospital in Boston. Since 2022, Ms. Schlaeppi has been recognized as Directorship Certified[] by the National Association of Corporate Directors ("NACD") and has been recognized as a Board Leadership Fellow by the NACD annually from 2017 2022. Prior to founding Stratevise, Ms. Schlaeppi served as General Counsel at Global Enterprise Technologies, Passport & ID, a high security document printing solutions provider and systems integrator, from 2007 to 2011 and as Executive Vice President, General Counsel and Corporate IP Officer at Organon BioSciences, a global pharmaceutical, animal health and biotech group based in the Netherlands, from 2006 until its sale in 2007. From 1999 to 2006, Ms. Schlaeppi was a partner at the Boston based law firm of Palmer & Dodge LLP, where she served as Chairperson of that firm's International Practice Group. From 1995 to 1998, Ms. Schlaeppi served in senior positions at Johnson Controls, Inc., a NYSE listed diversified indtrial company, including as General Counsel Europe. Ms. Schlaeppi has a Bachelor of Arts from Princeton University and a JD from the Columbia University School of Law. - YvonneE.Schlaeppi，自2018年4月起担任董事。Schlaeppi女士从2011年开始担任Stratevise LLC的管理合伙人，这是一家由她联合创立的国际战略咨询公司。Schlaeppi女士自2014年以来一直担任Stallergenes Greer plc（一家在巴黎泛欧交易所上市的梦百合公司）的董事会成员。Schlaeppi从2014年到2015年担任Allergy Immunotherapy Companies，Ares Allergy Holdings Inc.和Greer Laboratories，Inc.董事。自2015年以来，Schlaeppi女士一直担任波士顿Brigham and Women&8217；s Hospital网络医学部的外部咨询委员会成员。Schlaeppi女士于2017年被美国公司董事协会（National Association of Corporate Directors）认可为董事会领导研究员。在创立Stratevise之前，Schlaeppi女士于2007年至2011年担任全球企业技术公司Passport&ID的总法律顾问，该公司是一家高安全性文档打印解决方案提供商和系统集成商，并担任Organon Biosciences的执行Vice President、总法律顾问和公司IP官，Organon Biosciences是一家全球性制药公司，2006年至2007年，总部设在荷兰的动物保健和生物技术集团。从1999年到2006年，她曾担任Palmer&Dodge公司（位于波士顿的律师事务所）的合伙人，在那里她曾担任该公司的国际实践集团的主席。Schlaeppi女士从1995年到1998年在纽约证券交易所上市的多元化工业公司美国江森自控有限公司担任高级职位，包括担任欧洲总法律顾问。
- Yvonne E. Schlaeppi has been a director since April 2018. Since 2011, Ms. Schlaeppi has served as a Managing Partner of Stratevise LLC, an international strategic advisory firm that she co founded. From 2022 through its sale in 2024, Ms. Schlaeppi served on the board of OpGen, Inc., a NASDAQ listed molecular diagnostics company. From 2016 through its going private in 2019, Ms. Schlaeppi served on the board of directors of Stallergenes Greer plc, a pharmaceutical company traded on the Euronext Paris exchange. From 2014 to 2015, Ms. Schlaeppi served on the boards of directors of allergy immunotherapy companies, Ares Allergy Holdings Inc. and Greer Laboratories, Inc. Since 2015, Ms. Schlaeppi has been a member of the External Advisory Council to the Channing Division of Network Medicine of Brigham and Women's Hospital in Boston. Since 2022, Ms. Schlaeppi has been recognized as Directorship Certified[] by the National Association of Corporate Directors ("NACD") and has been recognized as a Board Leadership Fellow by the NACD annually from 2017 2022. Prior to founding Stratevise, Ms. Schlaeppi served as General Counsel at Global Enterprise Technologies, Passport & ID, a high security document printing solutions provider and systems integrator, from 2007 to 2011 and as Executive Vice President, General Counsel and Corporate IP Officer at Organon BioSciences, a global pharmaceutical, animal health and biotech group based in the Netherlands, from 2006 until its sale in 2007. From 1999 to 2006, Ms. Schlaeppi was a partner at the Boston based law firm of Palmer & Dodge LLP, where she served as Chairperson of that firm's International Practice Group. From 1995 to 1998, Ms. Schlaeppi served in senior positions at Johnson Controls, Inc., a NYSE listed diversified indtrial company, including as General Counsel Europe. Ms. Schlaeppi has a Bachelor of Arts from Princeton University and a JD from the Columbia University School of Law.
- Alexis P. Michas
-
Alexis P. Michas自2022年6月起担任董事。Michas先生凭借在多家主要运营公司的经验，贡献了数十年经验丰富的董事会领导。Michas先生是瞻博网络投资公司的创始人和管理合伙人，他通过在其他上市公司董事会任职获得了丰富的公司治理经验，以及他在一系列领域的成功私募股权和公共股权投资的良好记录。Michas先生自2008年起担任Juniper Investment Company，LLC的创始人和管理合伙人，此外，他还是Aetolian Investors，LLC（一家注册商品池运营商）的负责人、BorgWarner Inc.董事会的非执行主席、Revvity，Inc.董事会的非执行主席、Atlantic Investment Management，Inc.管理的基金的董事，以及私人控股的Theragenics Corporation的董事会成员。Michas先生还曾担任Lincoln Educational Services Corporation董事会非执行主席至2015年，并担任Allied Motion科技技术公司（现为Allient Inc.）董事至2017年7月。米查斯先生在2023年4月之前一直担任雅典学院的美国非营利组织Trtees委员会主席。Michas先生获得了哈佛学院的文学学士学位和哈佛大学BINCE School的BINCE Administration硕士学位。
Alexis P. Michas has been a director since June 2022. Mr. Michas contributes decades of seasoned board leadership grounded in hands on experience with multiple, major operating companies. Mr. Michas is the founder and Managing Partner of Juniper Investment Company, and he has gained extensive corporate governance experience through his service on other public company boards together with his proven track record of successful private equity and public equity investments across a range of sectors. In addition to being the founder and Managing Partner of Juniper Investment Company, LLC since 2008, Mr. Michas is also a Principal of Aetolian Investors, LLC, a registered commodity pool operator, the non executive Chairman of the board of BorgWarner Inc., the non executive Chairman of the board of Revvity, Inc., a director of funds managed by Atlantic Investment Management, Inc., and is also on the board of privately held Theragenics Corporation. Mr. Michas also served as the non executive Chairman of the board of Lincoln Educational Services Corporation until 2015, and as a director of Allied Motion Technologies, Inc. (now Allient Inc.) until July 2017. Mr. Michas served as the Chairman of the U.S. Board of Trtees of Athens College, a non profit organization until April 2023. Mr. Michas received a Bachelor of Arts degree from Harvard College and a Master of Biness Administration degree from Harvard Biness School. - Alexis P. Michas自2022年6月起担任董事。Michas先生凭借在多家主要运营公司的经验，贡献了数十年经验丰富的董事会领导。Michas先生是瞻博网络投资公司的创始人和管理合伙人，他通过在其他上市公司董事会任职获得了丰富的公司治理经验，以及他在一系列领域的成功私募股权和公共股权投资的良好记录。Michas先生自2008年起担任Juniper Investment Company，LLC的创始人和管理合伙人，此外，他还是Aetolian Investors，LLC（一家注册商品池运营商）的负责人、BorgWarner Inc.董事会的非执行主席、Revvity，Inc.董事会的非执行主席、Atlantic Investment Management，Inc.管理的基金的董事，以及私人控股的Theragenics Corporation的董事会成员。Michas先生还曾担任Lincoln Educational Services Corporation董事会非执行主席至2015年，并担任Allied Motion科技技术公司（现为Allient Inc.）董事至2017年7月。米查斯先生在2023年4月之前一直担任雅典学院的美国非营利组织Trtees委员会主席。Michas先生获得了哈佛学院的文学学士学位和哈佛大学BINCE School的BINCE Administration硕士学位。
- Alexis P. Michas has been a director since June 2022. Mr. Michas contributes decades of seasoned board leadership grounded in hands on experience with multiple, major operating companies. Mr. Michas is the founder and Managing Partner of Juniper Investment Company, and he has gained extensive corporate governance experience through his service on other public company boards together with his proven track record of successful private equity and public equity investments across a range of sectors. In addition to being the founder and Managing Partner of Juniper Investment Company, LLC since 2008, Mr. Michas is also a Principal of Aetolian Investors, LLC, a registered commodity pool operator, the non executive Chairman of the board of BorgWarner Inc., the non executive Chairman of the board of Revvity, Inc., a director of funds managed by Atlantic Investment Management, Inc., and is also on the board of privately held Theragenics Corporation. Mr. Michas also served as the non executive Chairman of the board of Lincoln Educational Services Corporation until 2015, and as a director of Allied Motion Technologies, Inc. (now Allient Inc.) until July 2017. Mr. Michas served as the Chairman of the U.S. Board of Trtees of Athens College, a non profit organization until April 2023. Mr. Michas received a Bachelor of Arts degree from Harvard College and a Master of Biness Administration degree from Harvard Biness School.
- Jorik Ittmann
-
Jorik Ittmann，于2024年9月加入公司，担任产品识别部门的销售和营销副总裁，并于2025年6月晋升为产品识别高级副总裁。Ittmann先生带来20多年的全球销售和业务发展经验，横跨医疗保健和印刷技术行业。在加入AstroNova之前，Ittmann先生于2015年1月至2024年9月期间担任Health Link Solutions LLC的首席营收官，该公司是一家位于密苏里州路易斯市的患者安全产品供应商。Ittmann先生于2012年7月至2014年1月期间担任斑马技术 International，LLC的北美医疗保健副总裁，该公司是将一线工作流程数字化和自动化的产品和服务提供商Zebra Technologies Corporation的子公司。在此之前，Ittmann先生于2007年11月至2012年7月在患者识别产品提供商LaserBand LLC担任全球销售副总裁，并于2004年11月至2007年11月在该公司于2012年7月被斑马技术收购之前担任销售发展国际总监。
Jorik Ittmann has been the Company's President and Chief Executive Officer, and a member of the Board since Augt 2025. Mr. Ittmann joined the Company in September 2024 as Vice President of Sales and Marketing for the Product Identification segment and was promoted to Senior Vice President of Product Identification in June 2025. Prior to joining AstroNova, Mr. Ittmann served as the Chief Revenue Officer at Health Link Solutions LLC, a provider of patient safety products based in St, Louis, MO, from January 2015 through September 2024. Mr. Ittmann was Vice President of Healthcare North America at Zebra Technologies International, LLC, a subsidiary of Zebra Technologies Corporation, a provider of products and services to digitize and automate frontline workflows, from July 2012 to January 2014. Prior to that, Mr. Ittmann served as Vice President, Worldwide Sales from November 2007 to July 2012 and International Director of Sales Development from November 2004 to November 2007 at LaserBand LLC, a provider of patient identification products, before that company's acquisition by Zebra Technologies in July 2012. - Jorik Ittmann，于2024年9月加入公司，担任产品识别部门的销售和营销副总裁，并于2025年6月晋升为产品识别高级副总裁。Ittmann先生带来20多年的全球销售和业务发展经验，横跨医疗保健和印刷技术行业。在加入AstroNova之前，Ittmann先生于2015年1月至2024年9月期间担任Health Link Solutions LLC的首席营收官，该公司是一家位于密苏里州路易斯市的患者安全产品供应商。Ittmann先生于2012年7月至2014年1月期间担任斑马技术 International，LLC的北美医疗保健副总裁，该公司是将一线工作流程数字化和自动化的产品和服务提供商Zebra Technologies Corporation的子公司。在此之前，Ittmann先生于2007年11月至2012年7月在患者识别产品提供商LaserBand LLC担任全球销售副总裁，并于2004年11月至2007年11月在该公司于2012年7月被斑马技术收购之前担任销售发展国际总监。
- Jorik Ittmann has been the Company's President and Chief Executive Officer, and a member of the Board since Augt 2025. Mr. Ittmann joined the Company in September 2024 as Vice President of Sales and Marketing for the Product Identification segment and was promoted to Senior Vice President of Product Identification in June 2025. Prior to joining AstroNova, Mr. Ittmann served as the Chief Revenue Officer at Health Link Solutions LLC, a provider of patient safety products based in St, Louis, MO, from January 2015 through September 2024. Mr. Ittmann was Vice President of Healthcare North America at Zebra Technologies International, LLC, a subsidiary of Zebra Technologies Corporation, a provider of products and services to digitize and automate frontline workflows, from July 2012 to January 2014. Prior to that, Mr. Ittmann served as Vice President, Worldwide Sales from November 2007 to July 2012 and International Director of Sales Development from November 2004 to November 2007 at LaserBand LLC, a provider of patient identification products, before that company's acquisition by Zebra Technologies in July 2012.
- Richard S. Warzala
-
Richard S. Warzala，他是Allied Motion Technologies， Inc.的总裁、首席执行官兼董事会主席。“联合运动”。他于2002年加入Allied Motion担任总裁兼首席运营官。他于2006年被选为Allied Motion的董事，2009年被选为总裁兼首席执行官，并于2014年被选为Allied Motion的董事会主席。Allied Motion设计，制造和销售精密和专业运动控制组件和系统，市场包括车辆，医疗，航空航天和国防以及工业/电子。在加入Allied Motion之前，他曾担任Danaher Corporation’s Motion Components Group的总裁，并在American Precision Industries Inc.担任各种高级职位，包括公司副总裁和API Motion Division的总裁。
Richard S. Warzala has been a director since December 2017 and serves as Lead Independent Director. Currently, he is the Chairman, President and Chief Executive Officer of Allient Inc. (Nasdaq: ALNT), a developer of advanced electromagnetic products and systems, with an Enterprise Value of approximately $600 million, as it has grown its revenues both organically and through acquisitions from $15 million in 2002 to $530+ million currently. Mr. Warzala was elected a director of Allient in 2006, appointed President and Chief Executive Officer in 2009, and elected as the Chairman and Allient's board of directors in 2014. He formerly was a Biness Unit President at Danaher Corp. and President, API Motion, a division of then publicly traded American Precision Indtries until it was acquired. Mr. Warzala received a bachelor's degree and M.B.A. from SUNY at Buffalo, New York. - Richard S. Warzala，他是Allied Motion Technologies， Inc.的总裁、首席执行官兼董事会主席。“联合运动”。他于2002年加入Allied Motion担任总裁兼首席运营官。他于2006年被选为Allied Motion的董事，2009年被选为总裁兼首席执行官，并于2014年被选为Allied Motion的董事会主席。Allied Motion设计，制造和销售精密和专业运动控制组件和系统，市场包括车辆，医疗，航空航天和国防以及工业/电子。在加入Allied Motion之前，他曾担任Danaher Corporation’s Motion Components Group的总裁，并在American Precision Industries Inc.担任各种高级职位，包括公司副总裁和API Motion Division的总裁。
- Richard S. Warzala has been a director since December 2017 and serves as Lead Independent Director. Currently, he is the Chairman, President and Chief Executive Officer of Allient Inc. (Nasdaq: ALNT), a developer of advanced electromagnetic products and systems, with an Enterprise Value of approximately $600 million, as it has grown its revenues both organically and through acquisitions from $15 million in 2002 to $530+ million currently. Mr. Warzala was elected a director of Allient in 2006, appointed President and Chief Executive Officer in 2009, and elected as the Chairman and Allient's board of directors in 2014. He formerly was a Biness Unit President at Danaher Corp. and President, API Motion, a division of then publicly traded American Precision Indtries until it was acquired. Mr. Warzala received a bachelor's degree and M.B.A. from SUNY at Buffalo, New York.
- Mitchell I. Quain
-
Mitchell I. Quain，他于2019年1月加入董事会，并于2021年1月1日成为首席独立董事。自2020年以来，他一直担任American Securities执行委员会成员，并于2010年至2011年担任One Equity Partners（一家私募股权投资公司）的合伙人。他是一名特许金融分析师和“金融专家”，担任AstroNova， Inc.， Kensington Acquisitions V和Williams Industrial Holdings的董事会成员。此前，他曾任职于上市公司DeCrane Aircraft Holdings， Inc., Handy & Harman Ltd., Hardinge, Inc., HEICO Corporation, Jason Industries, Kensington Acquisitions, MagneTek, Inc., Mechanical Dynamics, Inc., RBC Bearings, Inc., Strategic Distribution, Tecumseh Products Company, Titan International, Xerium, Inc.的董事会，担任Register.com董事会的执行主席和Carlyle Group的高级顾问。
Mitchell I. Quain has been a director since Augt 2011. Mr. Quain has served on the Executive Council of American Securities, Inc., a private equity firm, since January 2020. From December 2011 to December 2019, Mr. Quain was a Senior Advisor at the private equity firm Carlyle Group. From January 2010 through December 2011, Mr. Quain was a Partner at One Equity Partners, a private investment firm. From 2006 through 2009, he was a Senior Director of ACI Capital Corp. From 2002 through 2005, Mr. Quain served as Chairman of Register.com, Inc., an internet services provider, and from 1997 to 2001 he was employed with ABN AMRO and its predecessors in several capacities, including Vice Chairman of Investment Banking. Mr. Quain previoly served as a director of DeCrane Aircraft Holdings, Inc., Handy & Harman Ltd., Hardinge Inc., HEICO Corporation, Kensington Capital Acquisition Corp. I, Kensington Capital Acquisition Corp. II, MagneTek, Inc., Mechanical Dynamics, Inc., Jason Indtries, RBC Bearings, Inc., Register.com, Inc., Tecumseh Products Company, Titan International, Inc., and Xerium Technologies, Inc. Mr. Quain received a bachelor's degree from the University of Pennsylvania and an M.B.A. from Harvard University. - Mitchell I. Quain，他于2019年1月加入董事会，并于2021年1月1日成为首席独立董事。自2020年以来，他一直担任American Securities执行委员会成员，并于2010年至2011年担任One Equity Partners（一家私募股权投资公司）的合伙人。他是一名特许金融分析师和“金融专家”，担任AstroNova， Inc.， Kensington Acquisitions V和Williams Industrial Holdings的董事会成员。此前，他曾任职于上市公司DeCrane Aircraft Holdings， Inc., Handy & Harman Ltd., Hardinge, Inc., HEICO Corporation, Jason Industries, Kensington Acquisitions, MagneTek, Inc., Mechanical Dynamics, Inc., RBC Bearings, Inc., Strategic Distribution, Tecumseh Products Company, Titan International, Xerium, Inc.的董事会，担任Register.com董事会的执行主席和Carlyle Group的高级顾问。
- Mitchell I. Quain has been a director since Augt 2011. Mr. Quain has served on the Executive Council of American Securities, Inc., a private equity firm, since January 2020. From December 2011 to December 2019, Mr. Quain was a Senior Advisor at the private equity firm Carlyle Group. From January 2010 through December 2011, Mr. Quain was a Partner at One Equity Partners, a private investment firm. From 2006 through 2009, he was a Senior Director of ACI Capital Corp. From 2002 through 2005, Mr. Quain served as Chairman of Register.com, Inc., an internet services provider, and from 1997 to 2001 he was employed with ABN AMRO and its predecessors in several capacities, including Vice Chairman of Investment Banking. Mr. Quain previoly served as a director of DeCrane Aircraft Holdings, Inc., Handy & Harman Ltd., Hardinge Inc., HEICO Corporation, Kensington Capital Acquisition Corp. I, Kensington Capital Acquisition Corp. II, MagneTek, Inc., Mechanical Dynamics, Inc., Jason Indtries, RBC Bearings, Inc., Register.com, Inc., Tecumseh Products Company, Titan International, Inc., and Xerium Technologies, Inc. Mr. Quain received a bachelor's degree from the University of Pennsylvania and an M.B.A. from Harvard University.
- Alexis P. Michas
-
Alexis P. Michas，他是Juniper Investment Company， LLC的创始人和管理合伙人（2008年以来）。Juniper也是Aetolian Investors， LLC（一家注册商品池运营商）的负责人。他持有Harvard College的文学学士学位和Harvard Business School的工商管理硕士学位。他是博格华纳公司（BorgWarner Inc.）董事会的非执行主席和AstroNova， Inc.的董事会成员，这两家公司都是上市公司。他也是Atlantic Investment Management， Inc.（私人持有的投资公司）管理的基金的董事，以及私人持有的Theragenics Corporation的董事会成员。他还担任Lincoln Educational Services Corporation董事会的非执行主席（直到2015年），以及Allied Motion Technologies， Inc.的董事（直到2017年7月）。Michas于2019年12月30日被任命为董事会非执行主席。
Alexis P. Michas,is the founder and has been Managing Partner of Juniper Investment Company, LLC since 2008. Juniper is also a Principal of Aetolian Investors, LLC, a registered commodity pool operator. Mr. Michas received a Bachelor of Arts degree from Harvard College and a Master of Business Administration degree from Harvard Business School. Mr. Michas is the Non-Executive Chairman of the board of BorgWarner Inc. and a board member of AstroNova, Inc., both of which are publicly traded. Mr. Michas is also a director of funds managed by Atlantic Investment Management, Inc., a privately held investment company, as well as a board member of privately held Theragenics Corporation. Mr. Michas also served as the Non-Executive Chairman of the board of Lincoln Educational Services Corporation until 2015, and as a director of Allied Motion Technologies, Inc. until July 2017. - Alexis P. Michas，他是Juniper Investment Company， LLC的创始人和管理合伙人（2008年以来）。Juniper也是Aetolian Investors， LLC（一家注册商品池运营商）的负责人。他持有Harvard College的文学学士学位和Harvard Business School的工商管理硕士学位。他是博格华纳公司（BorgWarner Inc.）董事会的非执行主席和AstroNova， Inc.的董事会成员，这两家公司都是上市公司。他也是Atlantic Investment Management， Inc.（私人持有的投资公司）管理的基金的董事，以及私人持有的Theragenics Corporation的董事会成员。他还担任Lincoln Educational Services Corporation董事会的非执行主席（直到2015年），以及Allied Motion Technologies， Inc.的董事（直到2017年7月）。Michas于2019年12月30日被任命为董事会非执行主席。
- Alexis P. Michas,is the founder and has been Managing Partner of Juniper Investment Company, LLC since 2008. Juniper is also a Principal of Aetolian Investors, LLC, a registered commodity pool operator. Mr. Michas received a Bachelor of Arts degree from Harvard College and a Master of Business Administration degree from Harvard Business School. Mr. Michas is the Non-Executive Chairman of the board of BorgWarner Inc. and a board member of AstroNova, Inc., both of which are publicly traded. Mr. Michas is also a director of funds managed by Atlantic Investment Management, Inc., a privately held investment company, as well as a board member of privately held Theragenics Corporation. Mr. Michas also served as the Non-Executive Chairman of the board of Lincoln Educational Services Corporation until 2015, and as a director of Allied Motion Technologies, Inc. until July 2017.
- Darius G. Nevin
-
Darius G. Nevin，自2022年起担任Psychemedics Corporation董事会成员，自2023年8月起担任董事长。自2010年以来，Nevin先生一直是G3 Capital Partners LLC的成员，该公司是安全、电信和经常性服务领域私募股权公司的顾问，也是附属投资控股公司G3 Investment Holdings LLC的成员。Nevin先生自2016年以来一直在Alarm.com控股，Inc.（纳斯达克：ALRM）的董事会任职，该公司是一家为家庭和企业主提供交互式安全解决方案的供应商，自2016年以来也一直在Cohealo，Inc.的董事会任职，该公司是一家由风险投资支持的技术和服务公司，为健康系统开发产品。在共同创立G3 Capital Partners，LLC之前，Nevin先生曾在2001年至2010年6月期间担任Protection One，Inc.的首席财务官，该公司当时是一家上市公司。从2013年7月到2017年2月被收购，他担任WCI社区，Inc.的董事和审计委员会主席，该公司当时是一家上市的社区开发商和豪华住宅建筑商。Nevin先生获得哈佛大学学士学位和芝加哥大学布斯商学院工商管理硕士学位。
Darius G. Nevin has been a director since March 2025, and Executive Chairman of the Board of Directors since July 31, 2025. Mr. Nevin is a highly respected finance executive with more than 30 years of experience, including as a former Chief Financial Officer of a publicly traded company and public company director on multiple boards. Mr. Nevin served for nine years as Chief Financial Officer at then publicly traded Protection One, Inc., one of the largest security monitoring companies in the United States during his tenure. In this role, he was instrumental in orchestrating a comprehensive financial turnaround that significantly enhanced operational efficiency, culminating in the successful sale of the company. Since 2016, he has served on the board of Alarm.com, a global leader in internet of things security and automation solutions. In 2022, Mr. Nevin joined the board of drug testing company Psychemedics Corporation, where he serves as Chairman. In addition, he served on the board of WCI Communities, Inc., a luxury homebuilder, from shortly after its initial public offering on the NYSE in 2013 until its sale in 2017. Mr. Nevin received a bachelor's degree from Harvard University and an M.B.A. from the University of Chicago Booth School of Biness. - Darius G. Nevin，自2022年起担任Psychemedics Corporation董事会成员，自2023年8月起担任董事长。自2010年以来，Nevin先生一直是G3 Capital Partners LLC的成员，该公司是安全、电信和经常性服务领域私募股权公司的顾问，也是附属投资控股公司G3 Investment Holdings LLC的成员。Nevin先生自2016年以来一直在Alarm.com控股，Inc.（纳斯达克：ALRM）的董事会任职，该公司是一家为家庭和企业主提供交互式安全解决方案的供应商，自2016年以来也一直在Cohealo，Inc.的董事会任职，该公司是一家由风险投资支持的技术和服务公司，为健康系统开发产品。在共同创立G3 Capital Partners，LLC之前，Nevin先生曾在2001年至2010年6月期间担任Protection One，Inc.的首席财务官，该公司当时是一家上市公司。从2013年7月到2017年2月被收购，他担任WCI社区，Inc.的董事和审计委员会主席，该公司当时是一家上市的社区开发商和豪华住宅建筑商。Nevin先生获得哈佛大学学士学位和芝加哥大学布斯商学院工商管理硕士学位。
- Darius G. Nevin has been a director since March 2025, and Executive Chairman of the Board of Directors since July 31, 2025. Mr. Nevin is a highly respected finance executive with more than 30 years of experience, including as a former Chief Financial Officer of a publicly traded company and public company director on multiple boards. Mr. Nevin served for nine years as Chief Financial Officer at then publicly traded Protection One, Inc., one of the largest security monitoring companies in the United States during his tenure. In this role, he was instrumental in orchestrating a comprehensive financial turnaround that significantly enhanced operational efficiency, culminating in the successful sale of the company. Since 2016, he has served on the board of Alarm.com, a global leader in internet of things security and automation solutions. In 2022, Mr. Nevin joined the board of drug testing company Psychemedics Corporation, where he serves as Chairman. In addition, he served on the board of WCI Communities, Inc., a luxury homebuilder, from shortly after its initial public offering on the NYSE in 2013 until its sale in 2017. Mr. Nevin received a bachelor's degree from Harvard University and an M.B.A. from the University of Chicago Booth School of Biness.
高管简历
中英对照 | 中文 | 英文- Tom Carll
Tom Carll于1989年加入该公司，自2011年以来一直担任航空航天Vice President和总经理。此前，Carll先生曾担任Astronova测试与测量产品集团的产品经理和全国销售经理，并自2004年Astronova航空航天业务集团成立以来一直担任该集团的产品经理和全国销售经理。
Tom Carll joined the Company in 1989 and has held the position of Vice President and General Manager—Aerospace since 2011. Previoly, Mr. Carll was Product Manager and National Sales Manager of the AstroNova Test & Measurement product group and, from its formation in 2004, the AstroNova Aerospace biness group.- Tom Carll于1989年加入该公司，自2011年以来一直担任航空航天Vice President和总经理。此前，Carll先生曾担任Astronova测试与测量产品集团的产品经理和全国销售经理，并自2004年Astronova航空航天业务集团成立以来一直担任该集团的产品经理和全国销售经理。
- Tom Carll joined the Company in 1989 and has held the position of Vice President and General Manager—Aerospace since 2011. Previoly, Mr. Carll was Product Manager and National Sales Manager of the AstroNova Test & Measurement product group and, from its formation in 2004, the AstroNova Aerospace biness group.
- Thomas D. DeByle
Thomas D. DeByle被任命为副总裁、首席财务官并担任公司财务主管，自2024年6月17日起生效。在加入公司之前，DeByle先生从2021年10月至2022年8月通过将BINES出售给Altium Packaging担任Plastic Indtries的首席财务官，Plastic Indtries是一家为食品、特种饮料、乳制品、健康、lLness、hoehold和工业产品市场提供吹塑高密度聚乙烯瓶的制造商。DeByle先生还曾于2019年9月至2021年6月担任NN，Inc.的高级副总裁兼首席财务官，NN，Inc.是一家在机械加工、冲压和精密金属电镀方面拥有丰富经验的全球精密零部件制造商，并于2008年3月至2019年9月担任Standex International Corporation的副总裁、首席财务官和财务主管，该公司是一家在五个广泛的BINSE细分领域（电子、雕刻、科学、工程技术和专业解决方案）的全球多精度制造商。此外，DeByle先生目前还在Chase Corporation和Good Foods Group，LLC的董事会任职。
Thomas D. DeByle was appointed Vice President, Chief Financial Officer, and Treasurer of the Company effective June 17, 2024. Prior to joining the Company, Mr. DeByle served as Chief Financial Officer for Plastic Indtries, a manufacturer of blow molded, high density polyethylene bottles for food, specialty beverage, dairy, health, llness, hoehold and indtrial product markets, from October 2021 through the sale of the biness to Altium Packaging in Augt 2022. Mr. DeByle also held the position of Sr. Vice President and Chief Financial Officer of NN, Inc., a global precision component manufacturer with extensive experience in machining, stamping, and precio metal plating from September 2019 to June 2021, and Vice President, Chief Financial Officer and Treasurer of Standex International Corporation, a global multi indtry manufacturer in five broad biness segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions from March 2008 through September 2019. Additionally, Mr. DeByle currently serves on the Board of Directors of Chase Corporation and Good Foods Group, LLC.- Thomas D. DeByle被任命为副总裁、首席财务官并担任公司财务主管，自2024年6月17日起生效。在加入公司之前，DeByle先生从2021年10月至2022年8月通过将BINES出售给Altium Packaging担任Plastic Indtries的首席财务官，Plastic Indtries是一家为食品、特种饮料、乳制品、健康、lLness、hoehold和工业产品市场提供吹塑高密度聚乙烯瓶的制造商。DeByle先生还曾于2019年9月至2021年6月担任NN，Inc.的高级副总裁兼首席财务官，NN，Inc.是一家在机械加工、冲压和精密金属电镀方面拥有丰富经验的全球精密零部件制造商，并于2008年3月至2019年9月担任Standex International Corporation的副总裁、首席财务官和财务主管，该公司是一家在五个广泛的BINSE细分领域（电子、雕刻、科学、工程技术和专业解决方案）的全球多精度制造商。此外，DeByle先生目前还在Chase Corporation和Good Foods Group，LLC的董事会任职。
- Thomas D. DeByle was appointed Vice President, Chief Financial Officer, and Treasurer of the Company effective June 17, 2024. Prior to joining the Company, Mr. DeByle served as Chief Financial Officer for Plastic Indtries, a manufacturer of blow molded, high density polyethylene bottles for food, specialty beverage, dairy, health, llness, hoehold and indtrial product markets, from October 2021 through the sale of the biness to Altium Packaging in Augt 2022. Mr. DeByle also held the position of Sr. Vice President and Chief Financial Officer of NN, Inc., a global precision component manufacturer with extensive experience in machining, stamping, and precio metal plating from September 2019 to June 2021, and Vice President, Chief Financial Officer and Treasurer of Standex International Corporation, a global multi indtry manufacturer in five broad biness segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions from March 2008 through September 2019. Additionally, Mr. DeByle currently serves on the Board of Directors of Chase Corporation and Good Foods Group, LLC.
- Jorik Ittmann
Jorik Ittmann，于2024年9月加入公司，担任产品识别部门的销售和营销副总裁，并于2025年6月晋升为产品识别高级副总裁。Ittmann先生带来20多年的全球销售和业务发展经验，横跨医疗保健和印刷技术行业。在加入AstroNova之前，Ittmann先生于2015年1月至2024年9月期间担任Health Link Solutions LLC的首席营收官，该公司是一家位于密苏里州路易斯市的患者安全产品供应商。Ittmann先生于2012年7月至2014年1月期间担任斑马技术 International，LLC的北美医疗保健副总裁，该公司是将一线工作流程数字化和自动化的产品和服务提供商Zebra Technologies Corporation的子公司。在此之前，Ittmann先生于2007年11月至2012年7月在患者识别产品提供商LaserBand LLC担任全球销售副总裁，并于2004年11月至2007年11月在该公司于2012年7月被斑马技术收购之前担任销售发展国际总监。
Jorik Ittmann has been the Company's President and Chief Executive Officer, and a member of the Board since Augt 2025. Mr. Ittmann joined the Company in September 2024 as Vice President of Sales and Marketing for the Product Identification segment and was promoted to Senior Vice President of Product Identification in June 2025. Prior to joining AstroNova, Mr. Ittmann served as the Chief Revenue Officer at Health Link Solutions LLC, a provider of patient safety products based in St, Louis, MO, from January 2015 through September 2024. Mr. Ittmann was Vice President of Healthcare North America at Zebra Technologies International, LLC, a subsidiary of Zebra Technologies Corporation, a provider of products and services to digitize and automate frontline workflows, from July 2012 to January 2014. Prior to that, Mr. Ittmann served as Vice President, Worldwide Sales from November 2007 to July 2012 and International Director of Sales Development from November 2004 to November 2007 at LaserBand LLC, a provider of patient identification products, before that company's acquisition by Zebra Technologies in July 2012.- Jorik Ittmann，于2024年9月加入公司，担任产品识别部门的销售和营销副总裁，并于2025年6月晋升为产品识别高级副总裁。Ittmann先生带来20多年的全球销售和业务发展经验，横跨医疗保健和印刷技术行业。在加入AstroNova之前，Ittmann先生于2015年1月至2024年9月期间担任Health Link Solutions LLC的首席营收官，该公司是一家位于密苏里州路易斯市的患者安全产品供应商。Ittmann先生于2012年7月至2014年1月期间担任斑马技术 International，LLC的北美医疗保健副总裁，该公司是将一线工作流程数字化和自动化的产品和服务提供商Zebra Technologies Corporation的子公司。在此之前，Ittmann先生于2007年11月至2012年7月在患者识别产品提供商LaserBand LLC担任全球销售副总裁，并于2004年11月至2007年11月在该公司于2012年7月被斑马技术收购之前担任销售发展国际总监。
- Jorik Ittmann has been the Company's President and Chief Executive Officer, and a member of the Board since Augt 2025. Mr. Ittmann joined the Company in September 2024 as Vice President of Sales and Marketing for the Product Identification segment and was promoted to Senior Vice President of Product Identification in June 2025. Prior to joining AstroNova, Mr. Ittmann served as the Chief Revenue Officer at Health Link Solutions LLC, a provider of patient safety products based in St, Louis, MO, from January 2015 through September 2024. Mr. Ittmann was Vice President of Healthcare North America at Zebra Technologies International, LLC, a subsidiary of Zebra Technologies Corporation, a provider of products and services to digitize and automate frontline workflows, from July 2012 to January 2014. Prior to that, Mr. Ittmann served as Vice President, Worldwide Sales from November 2007 to July 2012 and International Director of Sales Development from November 2004 to November 2007 at LaserBand LLC, a provider of patient identification products, before that company's acquisition by Zebra Technologies in July 2012.
- Padraig Finn
Padraig Finn被任命为产品识别高级副总裁，自2025年8月15日起生效。He previoly自2024年9月起担任EMEA销售总监一职。在加入公司之前，Finn先生于2022年7月至2024年9月期间担任AutoCoding Systems的英国和欧洲销售总监。在此之前，Finn先生在Linx Printing Technologies工作了超过16年，从2019年12月到2022年6月担任全球分销销售经理一职。
Padraig Finn was appointed Senior Vice President of Product Identification effective Augt 15, 2025. He previoly held the position of Director of Sales EMEA since September 2024. Prior to joining the Company, Mr. Finn served as UK and Europe Sales Director of AutoCoding Systems from July 2022 to September 2024. Prior to that, Mr. Finn spent over 16 years at Linx Printing Technologies holding the position of Global Distribution Sales Manager from December 2019 to June 2022.- Padraig Finn被任命为产品识别高级副总裁，自2025年8月15日起生效。He previoly自2024年9月起担任EMEA销售总监一职。在加入公司之前，Finn先生于2022年7月至2024年9月期间担任AutoCoding Systems的英国和欧洲销售总监。在此之前，Finn先生在Linx Printing Technologies工作了超过16年，从2019年12月到2022年6月担任全球分销销售经理一职。
- Padraig Finn was appointed Senior Vice President of Product Identification effective Augt 15, 2025. He previoly held the position of Director of Sales EMEA since September 2024. Prior to joining the Company, Mr. Finn served as UK and Europe Sales Director of AutoCoding Systems from July 2022 to September 2024. Prior to that, Mr. Finn spent over 16 years at Linx Printing Technologies holding the position of Global Distribution Sales Manager from December 2019 to June 2022.
- Michael J. Natalizia
Michael J. Natalizia，他被任命为Astro-Med公司的副总裁兼首席技术官于2012年3月9日。在此任命之前，自2005年以来，他担任公司产品开发总监。
Michael J. Natalizia was appointed Vice President—Technology & Strategic Alliances and Chief Technology Officer of the Company on March 9, 2012. Prior to this appointment, Mr. Natalizia had held the position of Director of Product Development of the Company since 2005.- Michael J. Natalizia，他被任命为Astro-Med公司的副总裁兼首席技术官于2012年3月9日。在此任命之前，自2005年以来，他担任公司产品开发总监。
- Michael J. Natalizia was appointed Vice President—Technology & Strategic Alliances and Chief Technology Officer of the Company on March 9, 2012. Prior to this appointment, Mr. Natalizia had held the position of Director of Product Development of the Company since 2005.
- Darius G. Nevin
Darius G. Nevin，自2022年起担任Psychemedics Corporation董事会成员，自2023年8月起担任董事长。自2010年以来，Nevin先生一直是G3 Capital Partners LLC的成员，该公司是安全、电信和经常性服务领域私募股权公司的顾问，也是附属投资控股公司G3 Investment Holdings LLC的成员。Nevin先生自2016年以来一直在Alarm.com控股，Inc.（纳斯达克：ALRM）的董事会任职，该公司是一家为家庭和企业主提供交互式安全解决方案的供应商，自2016年以来也一直在Cohealo，Inc.的董事会任职，该公司是一家由风险投资支持的技术和服务公司，为健康系统开发产品。在共同创立G3 Capital Partners，LLC之前，Nevin先生曾在2001年至2010年6月期间担任Protection One，Inc.的首席财务官，该公司当时是一家上市公司。从2013年7月到2017年2月被收购，他担任WCI社区，Inc.的董事和审计委员会主席，该公司当时是一家上市的社区开发商和豪华住宅建筑商。Nevin先生获得哈佛大学学士学位和芝加哥大学布斯商学院工商管理硕士学位。
Darius G. Nevin has been a director since March 2025, and Executive Chairman of the Board of Directors since July 31, 2025. Mr. Nevin is a highly respected finance executive with more than 30 years of experience, including as a former Chief Financial Officer of a publicly traded company and public company director on multiple boards. Mr. Nevin served for nine years as Chief Financial Officer at then publicly traded Protection One, Inc., one of the largest security monitoring companies in the United States during his tenure. In this role, he was instrumental in orchestrating a comprehensive financial turnaround that significantly enhanced operational efficiency, culminating in the successful sale of the company. Since 2016, he has served on the board of Alarm.com, a global leader in internet of things security and automation solutions. In 2022, Mr. Nevin joined the board of drug testing company Psychemedics Corporation, where he serves as Chairman. In addition, he served on the board of WCI Communities, Inc., a luxury homebuilder, from shortly after its initial public offering on the NYSE in 2013 until its sale in 2017. Mr. Nevin received a bachelor's degree from Harvard University and an M.B.A. from the University of Chicago Booth School of Biness.- Darius G. Nevin，自2022年起担任Psychemedics Corporation董事会成员，自2023年8月起担任董事长。自2010年以来，Nevin先生一直是G3 Capital Partners LLC的成员，该公司是安全、电信和经常性服务领域私募股权公司的顾问，也是附属投资控股公司G3 Investment Holdings LLC的成员。Nevin先生自2016年以来一直在Alarm.com控股，Inc.（纳斯达克：ALRM）的董事会任职，该公司是一家为家庭和企业主提供交互式安全解决方案的供应商，自2016年以来也一直在Cohealo，Inc.的董事会任职，该公司是一家由风险投资支持的技术和服务公司，为健康系统开发产品。在共同创立G3 Capital Partners，LLC之前，Nevin先生曾在2001年至2010年6月期间担任Protection One，Inc.的首席财务官，该公司当时是一家上市公司。从2013年7月到2017年2月被收购，他担任WCI社区，Inc.的董事和审计委员会主席，该公司当时是一家上市的社区开发商和豪华住宅建筑商。Nevin先生获得哈佛大学学士学位和芝加哥大学布斯商学院工商管理硕士学位。
- Darius G. Nevin has been a director since March 2025, and Executive Chairman of the Board of Directors since July 31, 2025. Mr. Nevin is a highly respected finance executive with more than 30 years of experience, including as a former Chief Financial Officer of a publicly traded company and public company director on multiple boards. Mr. Nevin served for nine years as Chief Financial Officer at then publicly traded Protection One, Inc., one of the largest security monitoring companies in the United States during his tenure. In this role, he was instrumental in orchestrating a comprehensive financial turnaround that significantly enhanced operational efficiency, culminating in the successful sale of the company. Since 2016, he has served on the board of Alarm.com, a global leader in internet of things security and automation solutions. In 2022, Mr. Nevin joined the board of drug testing company Psychemedics Corporation, where he serves as Chairman. In addition, he served on the board of WCI Communities, Inc., a luxury homebuilder, from shortly after its initial public offering on the NYSE in 2013 until its sale in 2017. Mr. Nevin received a bachelor's degree from Harvard University and an M.B.A. from the University of Chicago Booth School of Biness.